Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Karydas Daphne

Over the trailing 90 days, Karydas Daphne (Director at Mineralys Therapeutics, Inc.) traded $111K of stock (net selling $39K) across 2 companies, per 4 SEC Form 4 transactions.

Role: Director
Companies: MLYS CMPS
Window: Trailing 90 days · 4 transactions · CIK 1816952
Net activity: −$39K ($36K bought · $75K sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
MLYS	Mineralys Therapeutics, Inc.	3	$36K	$75K	−$39K
CMPS	COMPASS Pathways plc	1	—	—	$0

Transactions (4)

Date	Symbol	Type	Shares	Value	Description
2026-06-17	MLYS	Sell	3.0K	$75K	Open market or private sale
2026-06-17	MLYS	Buy	3.0K	$36K	Exercise or conversion of derivative security
2026-06-17	MLYS	Sell	3.0K	$0	Exercise or conversion of derivative security
2026-05-27	CMPS	Buy	21.1K	$0	Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Karydas's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free